Related Experiment Videos
Stimulant medication and attention deficit-hyperactivity disorder. The child's perspective
J Bowen1, T Fenton, L Rappaport
1Division of Ambulatory Pediatrics, Children's Hospital, Boston, Mass 02115.
American Journal of Diseases of Children (1960)
|March 1, 1991
Summary
Most children with attention deficit-hyperactivity disorder (ADHD) find stimulant medication helpful, despite side effects. Sustained-release formulations may improve acceptability for pediatric ADHD treatment.
Area of Science:
- Pediatric Psychology
- Neurodevelopmental Disorders
- Pharmacology
Background:
- Attention deficit-hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in children.
- Stimulant medications, such as methylphenidate, are frequently prescribed for ADHD management.
- Understanding children's perspectives on medication is crucial for treatment adherence and effectiveness.
Purpose of the Study:
- To investigate children's knowledge and attitudes towards stimulant medication for ADHD.
- To explore the relationship between perceived helpfulness, side effects, and medication preferences in children with ADHD.
- To compare children's and parents' views on stimulant treatment.
Main Methods:
- A study involving 58 children diagnosed with ADHD and receiving stimulant medication.
- Participants were recruited from learning disability clinics at two teaching hospitals.
- Data collected via separate questionnaires for children and parents regarding medication experiences.
Main Results:
- 89% of children perceived stimulant medication as helpful, and 78% liked or were indifferent to it.
- A high rate of side effects (85%) was reported by children.
- Children preferring to stop medication were more likely to find it unhelpful and were on standard methylphenidate, not long-acting forms.
Conclusions:
- Directly eliciting children's perspectives on ADHD medication is essential.
- Sustained-release stimulant preparations may offer greater acceptability for children with ADHD.
- Future research should consider patient-reported outcomes in pediatric ADHD pharmacotherapy.